STANZIONE, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 58.470
EU - Europa 3.922
AS - Asia 764
Continente sconosciuto - Info sul continente non disponibili 23
SA - Sud America 16
OC - Oceania 9
AF - Africa 2
Totale 63.206
Nazione #
US - Stati Uniti d'America 58.451
DE - Germania 1.203
UA - Ucraina 857
IE - Irlanda 501
CN - Cina 488
IT - Italia 276
FR - Francia 253
GB - Regno Unito 225
FI - Finlandia 175
PL - Polonia 172
KR - Corea 165
SE - Svezia 141
RU - Federazione Russa 46
BE - Belgio 32
JP - Giappone 22
EU - Europa 21
VN - Vietnam 21
CA - Canada 15
SG - Singapore 13
KG - Kirghizistan 10
NL - Olanda 10
IL - Israele 9
AU - Australia 8
BR - Brasile 8
RO - Romania 7
TR - Turchia 7
ES - Italia 5
HK - Hong Kong 5
IN - India 5
AT - Austria 4
CL - Cile 4
DK - Danimarca 4
CH - Svizzera 3
CO - Colombia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
DM - Dominica 2
EG - Egitto 2
GR - Grecia 2
IQ - Iraq 2
IR - Iran 2
MX - Messico 2
MY - Malesia 2
PH - Filippine 2
TH - Thailandia 2
UZ - Uzbekistan 2
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BY - Bielorussia 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 63.206
Città #
Woodbridge 19.190
Wilmington 15.614
Houston 14.704
Fairfield 1.830
Ann Arbor 1.474
Jacksonville 793
Ashburn 780
Seattle 689
Cambridge 630
Dublin 495
Chandler 485
Medford 377
Dearborn 275
Beijing 246
Lawrence 174
Kraków 170
New York 113
San Diego 95
Zhengzhou 93
Mülheim 75
Menlo Park 69
Milan 62
Rome 57
Falls Church 51
University Park 34
Verona 32
Brussels 31
London 29
Nürnberg 28
Mcallen 27
Norwalk 26
Detroit 24
Mountain View 23
Palo Alto 20
Hefei 18
Nanjing 17
Shanghai 17
Kunming 16
St Louis 16
Boardman 13
Redwood City 13
San Mateo 13
Washington 13
Hanoi 12
Toronto 12
Phoenix 10
Dong Ket 9
Hangzhou 9
Chicago 8
Fuzhou 8
Guangzhou 8
Helsinki 8
Hounslow 8
Jinan 8
Saint Petersburg 8
Campi Bisenzio 7
Shenyang 7
Los Angeles 6
Nanchang 6
Redmond 6
Auburn Hills 5
Indiana 5
Leawood 5
Stockholm 5
São Paulo 5
Chengdu 4
Durham 4
Engelhard 4
Groningen 4
Rho 4
San Francisco 4
San Jose 4
Suceava 4
Bielefeld 3
Chiswick 3
Council Bluffs 3
Creede 3
Edinburgh 3
Fremont 3
Hebei 3
Islington 3
Kilburn 3
Knoxville 3
Kongens Lyngby 3
Lamswaarde 3
New Bedfont 3
Rosny-sous-bois 3
Wuhan 3
Benicarló 2
Bornova 2
Bristol 2
Cairo 2
Cebu City 2
Changchun 2
Chongqing 2
Costa Mesa 2
Del Norte 2
Florence 2
Genova 2
Glasgow 2
Totale 59.217
Nome #
The role of dopamine receptors on lower urinary tract function in Parkinson's disease patients 445
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 445
Spontaneous subarachnoid hemorrhage in an HIV patient 443
Serial determinations of leukocyte aggregation in patients with ischemic stroke 440
Intra-arterial Thrombectomy versus Standard Intravenous Thrombolysis in Patients with Anterior Circulation Stroke Caused by Intracranial Arterial Occlusions: A Single-center Experience 440
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 434
Collet-Sicard syndrome caused by a coiling of the internal carotid artery 431
Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis 428
Homeostatic changes of the endocannabinoid system in Parkinson's disease. 426
Serial determinations of leukocyte aggregation in patients with ischemic stroke 424
Effects of inhibitory rTMS on bladder function in Parkinson's disease patients 422
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 417
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 414
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 414
The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. 411
Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? 411
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease 410
Changes in cerebrovascular reactivity following low-frequency repetitive transcranial magnetic stimulation 409
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 409
SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status 409
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 409
Ultrasound evaluation of early changes in arterial dissection 406
Effects of L-dopa on urodynamic findings in Parkinson's disease patients: Acute vs. chronic administration 406
Long-term Results of Drug-Eluting Balloon Angioplasty for Treatment of Refractory Recurrent Carotid In-Stent Restenosis 405
Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease 404
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 404
The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson's disease 403
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease? 403
Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease 401
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 401
Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes 398
Perfusion-weighted dynamic susceptibility (DSC) MRI: basal ganglia hemodynamic changes after apomorphine in Parkinson's disease 396
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus 395
rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease 394
Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study 394
Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients 393
null 393
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. 393
Boundary cerebral infarct in a case of essential thrombocythemia 392
Urgent carotid endarterectomy: The role of serial ultrasound studies in early detection of plaque rupture 392
Temporal administration of entacapone with slow release L-dopa: pharmacokinetic profile and clinical outcome 392
Non ulcer dyspepsia is associated with helicobacter pylori infection in patients with Parkinson's disease 391
Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: a case report 391
123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study 389
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease 387
Floating carotid thrombus treated by intravenous heparin and endarterectomy. 386
Acute stroke treatment using the Penumbra endovascular mechanical thrombolysis device: a single-centre experience. 386
Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation 386
Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study 385
Therapy for dyskinesias in Parkinson’s disease patients 385
Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients 385
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. 384
Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale 384
Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine 384
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations 384
Transcranial direct current stimulation of the affected hemisphere does not accelerate recovery of acute stroke patients 384
Efficacy of systemic thrombolysis within 4.5 h from stroke symptom onset: a single-centre clinical and diffusion-perfusion 3T MRI study. 383
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 382
Leucocyte aggregation in acute cerebrovascular disease 381
Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine 381
Memory for time intervals is impaired in left hemi-Parkinson patients 380
Intracranial dissection and extracranial hypoplasia of the internal carotid artery. 380
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease 380
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease. 379
An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease 379
Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials 379
Saving the ischemic penumbra: Potential role for statins and phosphodiesterase inhibitors 378
Improvement of choreic movements by 1 Hz repetitive transcranial magnetic stimulation in Huntington's disease patients 378
Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. 378
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 377
Evaluation of basal ganglia haemodynamic changes with perfusion-weighted magnetic resonance imaging in patients with Parkinson's disease 377
EEG changes induced by vigabatrin monotherapy in focal epilepsy 377
Stroke prevention: managing modifiable risk factors 377
Leukocyte and platelet aggregation in patients with ischemic stroke: a case-control study 375
Early DEtection of wEaring off in Parkinson disease: the DEEP study 375
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 374
High-frequency rTMS improves time perception in Parkinson disease 374
Safety of early carotid artery stenting after systemic thrombolysis: a single center experience 373
Effectiveness of bornaprine on parkinsonian tremor 373
A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations 373
Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients - An ambulatory polysomnographic study 372
Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study 371
Protective effect of clonazepam on ischemic brain damage induced by 10-minute bilateral carotid occlusion in Mongolian gerbils. 371
Proposal for a Vascular Computed Tomography-Based Grading System in Posterior Circulation Stroke: A Single-Center Experience 371
Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis 368
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients 368
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 368
Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy 368
Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients 368
Leukocyte aggregation: a possible link between infection and ischemic stroke 367
Encouraging and positive trend towards treatment of acute ischemic stroke performed by vascular interventional radiologist 366
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 366
Letter by Legge et al regarding article, "Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts" 365
Effect of Vigabatrin on motor responses to transcranial magnetic stimulation: An effective tool to investigate in vivo GABAergic cortical inhibition in humans 364
Emotional processing in Parkinson's disease. A study using functional transcranial doppler sonography 360
An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study 360
Prevalence of patent foramen ovale in ischaemic stroke in italy: Results of SISIFO study 360
Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease 359
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 359
Motor and non-motor effects of PPN-DBS in PD patients: insights from intra-operative electrophysiology 358
Totale 39.019
Categoria #
all - tutte 103.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195.380 0 0 0 0 0 0 0 0 0 1.647 1.710 2.023
2019/202017.477 1.560 1.443 1.423 1.621 1.437 1.809 1.452 1.550 1.474 1.380 987 1.341
2020/20219.399 1.086 1.286 1.047 1.221 955 931 1.122 906 245 142 373 85
2021/20221.677 54 232 42 76 59 165 105 71 112 124 120 517
2022/20231.648 225 108 47 186 99 464 160 67 129 9 119 35
2023/2024400 67 21 45 8 44 107 20 59 19 10 0 0
Totale 63.625